References
- Kim KH. Safe sedation and hypnosis using dexmedetomidine for minimally invasive spine surgery in a prone position. Korean J Pain 2014; 27: 313-20. https://doi.org/10.3344/kjp.2014.27.4.313
- Ghobadifar MA, Kalani N. The potential role of intrathecal nefopam in the management of neuropathic pain. Korean J Pain 2014; 27: 301-2. https://doi.org/10.3344/kjp.2014.27.3.301
- Harden RN, Argoff CE, Williams DA. Intrathecal opioids for chronic pain: a call for evidence. Pain Med 2014; 15: 1823-4. https://doi.org/10.1111/pme.12576
- Mavropoulos G, Minguet G, Brichant JF. Alpha-2 adrenoreceptor agonists in anaesthesia and intensive care medicine. Rev Med Liege 2014; 69: 97-101.
- Isguzar O, Baris S, Bozkurt A, Can B, Bilge S, Ture H. Evaluation of antinociceptive and neurotoxic effects of intrathecal dexmedetomidine in rats. Balkan Med J 2012; 29: 354-7. https://doi.org/10.5152/balkanmedj.2012.034
- Kabalak A, Ekmekcioglu E, Ceylan A, Kahveci K. The synergistic antinociceptive interactions of morphine and dexmedetomidine in rats with nerve-ligation injury. Hippokratia 2013; 17: 326-31.
Cited by
- Choice of intrathecal drug in the treatment of neuropathic pain - new research and opinion vol.12, pp.10, 2015, https://doi.org/10.1080/17512433.2019.1659724
- Efficacy of adjuvant dexmedetomidine in supraclavicular brachial plexus block for intractable complex regional pain syndrome: A case report with a 3‐year follow‐up vol.45, pp.2, 2015, https://doi.org/10.1111/jcpt.13063